CA 125 is the most reliable serum marker for ovarian carcinoma. Whereas its role in the
screening of the malignancy is controversial, serum CA 125 assay is very useful for both the …

BACKGROUND The standard treatment for endometrial carcinoma is staging laparotomy
with total abdominal hysterectomy and bilateral salpingo‐oophorectomy. In an attempt to …

BACKGROUND. The purpose of the current study was to determine the potential therapeutic
role of lymphadenectomy in women with endometrioid corpus cancer. METHODS …

OBJECTIVE: Tumor markers with increased sensitivity and specificity for endometrial cancer
are needed to help monitor response to therapy and to detect recurrent disease. Currently …

Proteins that are expressed by both malignant and healthy fetal tissues are recognized as
oncofetal. These antigens are associated with cell proliferation and differentiation and are …

The aim of the study was to explore the clinical value of serum human epididymis secretory
protein E4 (HE4) and CA125 in endometrial carcinoma. From January 2010 to April 2012 …

Objective: We sought to determine the clinical utility of preoperative CA 125 measurement in
determining the need for lymphadenectomy in patients with endometrial carcinoma. Study …

Background Surgery plays an important role in the management of endometrial cancer at all
stages, particularly early clinical stage. There are still many unanswered questions …

Objective To evaluate whether human epididymis protein 4 (HE 4) and CA 125 correlate
with known high‐risk prognostic factors for endometrial cancer. Design Prospective …

PURPOSE: Endometrial carcinoma is the most common cancer of the lower female genital
tract in Europe and the United States. Faced with the growing incidence of endometrial …